Harel Insurance Investments & Financial Services’s AbbVie ABBV Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$226K	Buy	900 +100	+13%	+$21.5K	﹤0.01%	326
2026 Q1	$174K	Hold	800	–	–	﹤0.01%	320
2025 Q4	$183K	Buy	+800	New	+$182K	﹤0.01%	283
2024 Q2	–	Sell	-1,684	Closed	-$307K	–	543
2024 Q1	$307K	Buy	+1,684	New	+$290K	0.01%	210
2023 Q2	–	Sell	-17,590	Closed	-$2.78M	–	685
2023 Q1	$2.78M	Sell	17,590 -476	-3%	-$72.8K	0.06%	122
2022 Q4	$2.93M	Sell	18,066 -2,275	-11%	-$349K	0.06%	110
2022 Q3	$2.86M	Sell	20,341 -10,108	-33%	-$1.45M	0.07%	111
2022 Q2	$4.66M	Buy	30,449 +289	+1%	+$44.2K	0.1%	101
2022 Q1	$4.89M	Buy	+30,160	New	+$4.38M	0.08%	111
2021 Q4	–	Sell	-1,200	Closed	-$129K	–	742
2021 Q3	$129K	Sell	1,200 -4,124	-77%	-$471K	﹤0.01%	426
2021 Q2	$1.96M	Sell	5,324 -2,442	-31%	-$275K	0.04%	199
2021 Q1	$2.81M	Sell	7,766 -3,468	-31%	-$371K	0.05%	191
2020 Q4	$3.87M	Sell	11,234 -4,462	-28%	-$429K	0.09%	103
2020 Q3	$1.38M	Buy	15,696 +13,350	+569%	+$1.26M	0.05%	93
2020 Q2	$230K	Sell	2,346 -108	-4%	-$9.51K	0.01%	234
2020 Q1	$187K	Sell	2,454 -135	-5%	-$11.5K	0.01%	172
2019 Q4	$229K	Buy	+2,589	New	+$215K	0.01%	188
2019 Q1	–	Sell	-2,000	Closed	-$184K	–	449
2018 Q4	$184K	Hold	2,000	–	–	0.01%	181
2018 Q3	$189K	Hold	2,000	–	–	0.01%	205
2018 Q2	$185K	Hold	2,000	–	–	0.01%	190
2018 Q1	$189K	Sell	2,000 -2,000	-50%	-$220K	0.01%	213
2017 Q4	$387K	Buy	4,000 +3,000	+300%	+$283K	0.02%	156
2017 Q3	$89K	Hold	1,000	–	–	0.01%	241
2017 Q2	$73K	Hold	1,000	–	–	0.01%	269
2017 Q1	$64K	Sell	1,000 -2,230	-69%	-$140K	0.01%	246
2016 Q4	$202K	Sell	3,230 -120	-4%	-$7.33K	0.03%	109
2016 Q3	$211K	Buy	3,350 +130	+4%	+$8.42K	0.03%	110
2016 Q2	$199K	Buy	3,220 +50	+2%	+$3.05K	0.02%	160
2016 Q1	$181K	Sell	3,170 -1,030	-25%	-$57.4K	0.02%	118
2015 Q4	$249K	Buy	+4,200	New	+$242K	0.03%	95

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Harel Insurance Investments & Financial Services's ABBV Position: Q2 2026 in Review

Harel Insurance Investments & Financial Services increased its AbbVie (ABBV) stake by 13% in Q2 2026, buying an estimated $21.5K and bringing the position to 900 shares worth $226K. The position accounts for ﹤0.01% of the portfolio, ranked #326.

Harel Insurance Investments & Financial Services first reported a position in ABBV in Q4 2015 and has held it in 30 quarters since. The position peaked at $4.89M in Q1 2022. 2,919 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Harel Insurance Investments & Financial Services held 900 shares of AbbVie worth $226K as of Q2 2026.
Harel Insurance Investments & Financial Services bought 100 AbbVie shares in Q2 2026, an estimated $21.5K.
AbbVie made up ﹤0.01% of Harel Insurance Investments & Financial Services's portfolio in Q2 2026, its #326 holding.
Harel Insurance Investments & Financial Services first reported a position in AbbVie in Q4 2015 and has held it in 30 quarters since.
Harel Insurance Investments & Financial Services's AbbVie position peaked at $4.89M in Q1 2022.
2,919 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q2 2026, filed 29 Jul 2026.